Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain phosphoserine binding	SCAF8 SCAF4	1.89e-05	5	28	2	GO:1990269
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain binding	SCAF8 SCAF4	1.03e-04	11	28	2	GO:0099122
GeneOntologyMolecularFunction	phosphoserine residue binding	SCAF8 SCAF4	1.24e-04	12	28	2	GO:0050815
GeneOntologyMolecularFunction	RNA polymerase II complex binding	SCAF8 SCAF4	1.36e-03	39	28	2	GO:0000993
GeneOntologyMolecularFunction	RNA polymerase core enzyme binding	SCAF8 SCAF4	1.81e-03	45	28	2	GO:0043175
GeneOntologyMolecularFunction	translation initiation factor activity	EIF3A EIF4B	2.32e-03	51	28	2	GO:0003743
GeneOntologyMolecularFunction	RNA polymerase binding	SCAF8 SCAF4	3.73e-03	65	28	2	GO:0070063
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	SCAF8 SCAF4	3.85e-03	66	28	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	SCAF8 SCAF4	3.85e-03	66	28	2	GO:0001098
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	SCAF8 SCAF4	4.20e-03	69	28	2	GO:0045309
GeneOntologyBiologicalProcess	negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	1.65e-06	2	27	2	GO:2000805
GeneOntologyBiologicalProcess	negative regulation of termination of RNA polymerase II transcription	SCAF8 SCAF4	1.65e-06	2	27	2	GO:0120191
GeneOntologyBiologicalProcess	negative regulation of termination of DNA-templated transcription	SCAF8 SCAF4	4.95e-06	3	27	2	GO:0060567
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	4.95e-06	3	27	2	GO:2000804
GeneOntologyBiologicalProcess	termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	4.95e-06	3	27	2	GO:0030846
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription	SCAF8 SCAF4	9.89e-06	4	27	2	GO:1904594
GeneOntologyBiologicalProcess	regulation of termination of DNA-templated transcription	SCAF8 SCAF4	2.47e-05	6	27	2	GO:0031554
GeneOntologyBiologicalProcess	termination of RNA polymerase II transcription	SCAF8 SCAF4	1.96e-04	16	27	2	GO:0006369
Domain	SPOC	DIDO1 RBM15 PHF3	5.37e-08	6	27	3	PF07744
Domain	SPOC_C	DIDO1 RBM15 PHF3	5.37e-08	6	27	3	IPR012921
Domain	RRM_1	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	1.08e-05	208	27	5	PF00076
Domain	RRM	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	1.33e-05	217	27	5	SM00360
Domain	RRM_dom	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	1.65e-05	227	27	5	IPR000504
Domain	RRM	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	1.75e-05	230	27	5	PS50102
Domain	-	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	2.33e-05	244	27	5	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	3.05e-05	258	27	5	IPR012677
Domain	RNA_pol_II-bd	SCAF8 SCAF4	4.21e-05	7	27	2	IPR006903
Domain	TFS2M	DIDO1 PHF3	4.21e-05	7	27	2	SM00510
Domain	CTD_bind	SCAF8 SCAF4	4.21e-05	7	27	2	PF04818
Domain	TFIIS_M	DIDO1 PHF3	4.21e-05	7	27	2	PF07500
Domain	RPR	SCAF8 SCAF4	5.61e-05	8	27	2	SM00582
Domain	CID_dom	SCAF8 SCAF4	5.61e-05	8	27	2	IPR006569
Domain	TFIIS_cen_dom	DIDO1 PHF3	5.61e-05	8	27	2	IPR003618
Domain	-	DIDO1 PHF3	5.61e-05	8	27	2	1.10.472.30
Domain	CID	SCAF8 SCAF4	5.61e-05	8	27	2	PS51391
Domain	TFIIS_CENTRAL	DIDO1 PHF3	5.61e-05	8	27	2	PS51321
Domain	-	SCAF8 SCAF4	6.40e-04	26	27	2	1.25.40.90
Domain	ENTH_VHS	SCAF8 SCAF4	7.98e-04	29	27	2	IPR008942
Domain	Zinc_finger_PHD-type_CS	DIDO1 PHF3	3.96e-03	65	27	2	IPR019786
Domain	PHD	DIDO1 PHF3	5.23e-03	75	27	2	PF00628
Domain	Znf_PHD-finger	DIDO1 PHF3	5.79e-03	79	27	2	IPR019787
Domain	PHD	DIDO1 PHF3	7.29e-03	89	27	2	SM00249
Domain	Znf_PHD	DIDO1 PHF3	7.61e-03	91	27	2	IPR001965
Domain	ZF_PHD_2	DIDO1 PHF3	8.27e-03	95	27	2	PS50016
Domain	ZF_PHD_1	DIDO1 PHF3	8.44e-03	96	27	2	PS01359
Domain	Znf_FYVE_PHD	DIDO1 PHF3	1.90e-02	147	27	2	IPR011011
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GIGYF2 DIDO1 ZNF106 RBM15 RNF169 ZNF592 SCAF8 PHF3 CCDC9 EIF4B SCAF4	9.41e-12	774	28	11	15302935
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DIDO1 RNF169 EIF3A ZNF592 SCAF8 PHF3 EPB41L1 EIF4B FBXL6 SCAF4	1.37e-07	1497	28	10	31527615
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DIDO1 RBM15 EIF3A ZNF592 PHF3 EIF4B	3.73e-07	361	28	6	26167880
Pubmed	SCAF4 and SCAF8, mRNA Anti-Terminator Proteins.	SCAF8 SCAF4	6.25e-07	2	28	2	31104839
Pubmed	A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3.	EIF3A EIF4B	6.25e-07	2	28	2	8816444
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	DIDO1 ZNF106 RBM15 RNF169 EIF3A ZNF592 PHF3 EIF4B	7.79e-07	989	28	8	36424410
Pubmed	Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II.	SCAF8 SCAF4	1.87e-06	3	28	2	18550522
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GIGYF2 ZNF106 RBM15 ZNF592 EIF4B SCAF4	2.38e-06	497	28	6	36774506
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DIDO1 RBM15 RNF169 NCAPH PHF3 EPB41L1	2.55e-06	503	28	6	16964243
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	GIGYF2 DIDO1 RBM15 EIF3A CCDC9 EIF4B SCAF4	2.73e-06	807	28	7	22681889
Pubmed	Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals.	EIF3A EIF4B	3.75e-06	4	28	2	19289497
Pubmed	The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.	EIF3A EIF4B	3.75e-06	4	28	2	16763566
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GIGYF2 ZNF106 RBM15 DOCK6 PHF3 EPB41L1 EIF4B	4.18e-06	861	28	7	36931259
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	GIGYF2 DIDO1 RBM15 RNF169 PHF3 EIF4B SCAF4	8.18e-06	954	28	7	36373674
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DIDO1 RBM15 RNF169 EIF3A NCAPH ZNF592 PHF3	1.21e-05	1014	28	7	32416067
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	GIGYF2 RNF169 ZNF592 SCAF8	1.41e-05	184	28	4	32908313
Pubmed	The protein interaction landscape of the human CMGC kinase group.	DIDO1 RBM15 RNF169 PHF3 EPB41L1 SNRNP35	1.61e-05	695	28	6	23602568
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GIGYF2 SCAF8 PHF3 ZFR2 EPB41L1	1.69e-05	407	28	5	12693553
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	DIDO1 EIF3A SCAF8 SCAF4	2.83e-05	220	28	4	24550385
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	GIGYF2 DIDO1 NCAPH EIF4B	5.11e-05	256	28	4	33397691
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	RBM15 EIF3A CCDC9 EIF4B	5.27e-05	258	28	4	37794589
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	DIDO1 ZNF106 RBM15 RNF169 PHF3 FBXL6 SCAF4	5.78e-05	1294	28	7	30804502
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GIGYF2 DIDO1 NCAPH PHF3 SCAF4	7.00e-05	549	28	5	38280479
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	GIGYF2 RBM15 EIF3A CCDC9 EIF4B	7.13e-05	551	28	5	34728620
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GIGYF2 DIDO1 EIF3A NCAPH EIF4B SCAF4	8.38e-05	934	28	6	33916271
Pubmed	Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling.	GIGYF2 DIDO1	9.49e-05	18	28	2	19640993
Pubmed	The contribution of de novo coding mutations to autism spectrum disorder.	GIGYF2 PHF3	9.49e-05	18	28	2	25363768
Pubmed	Tagging genes with cassette-exchange sites.	GIGYF2 DIDO1 RNF169 SCAF8	1.44e-04	335	28	4	15741177
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	RBM15 SCAF8 SCAF4 SNRNP35	1.65e-04	347	28	4	16033648
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF106 RNF169 SCAF8 PHF3 SNRNP35	2.70e-04	733	28	5	34672954
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	ZNF106 RBM15 EIF3A SCAF8	2.92e-04	403	28	4	35253629
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	DIDO1 RBM15 NCAPH SCAF8 EIF4B	3.07e-04	754	28	5	35906200
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	RBM15 EIF3A ZNF592 EIF4B	4.10e-04	441	28	4	31239290
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DIDO1 RBM15 EIF3A NCAPH PHF3 EIF4B	4.19e-04	1257	28	6	36526897
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZNF106 RNF169 PHF3 EIF4B	4.21e-04	444	28	4	34795231
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZNF106 RNF169 PHF3 CCDC9	4.54e-04	453	28	4	29656893
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	GIGYF2 RBM15 EIF3A ZNF592 PHF3	5.22e-04	847	28	5	35850772
Pubmed	Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome.	RBM15 EIF3A	5.53e-04	43	28	2	34672947
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	GIGYF2 SCAF8 PHF3	5.76e-04	203	28	3	22083510
Pubmed	A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.	GIGYF2 EIF3A	5.79e-04	44	28	2	26471122
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP68 RNF169 EIF3A SCAF4	6.23e-04	493	28	4	15368895
Pubmed	The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.	GIGYF2 EIF4B	6.33e-04	46	28	2	34265304
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	GIGYF2 EIF3A EIF4B	6.90e-04	216	28	3	31519766
Pubmed	PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.	GIGYF2 EIF4B	7.18e-04	49	28	2	31762063
Pubmed	Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA.	EIF3A EIF4B	7.18e-04	49	28	2	24248602
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ZNF106 RBM15 RNF169	7.47e-04	222	28	3	37071664
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	GIGYF2 RBM15 NCAPH EIF4B SCAF4	7.67e-04	922	28	5	27609421
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CEP68 GIGYF2 PHF3	7.77e-04	225	28	3	12168954
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	GIGYF2 DIDO1 EIF3A NCAPH SCAF8 EIF4B	7.82e-04	1415	28	6	28515276
Interaction	SRPK2 interactions	DIDO1 RBM15 EIF3A ZNF592 EPB41L1 EIF4B FBXL6 SCAF4 SNRNP35	2.29e-07	717	27	9	int:SRPK2
Interaction	PRMT1 interactions	FGF2 GIGYF2 RBM15 EIF3A NCAPH ENDOG CCDC9 EIF4B	2.01e-05	929	27	8	int:PRMT1
Interaction	PPP2R2A interactions	GIGYF2 EIF3A NCAPH CCDC9 FBXL6	4.43e-05	301	27	5	int:PPP2R2A
Interaction	GAGE5 interactions	DIDO1 PHF3 SCAF4	4.54e-05	52	27	3	int:GAGE5
Interaction	FBXO22 interactions	GIGYF2 ZNF106 RBM15 ZNF592 EIF4B SCAF4	6.60e-05	540	27	6	int:FBXO22
Interaction	PHLPP1 interactions	GIGYF2 DIDO1 RBM15 NCAPH EIF4B	7.16e-05	333	27	5	int:PHLPP1
Interaction	POLR2C interactions	NUDT19 DIDO1 SCAF8 PHF3 SCAF4	7.68e-05	338	27	5	int:POLR2C
Interaction	EIF3A interactions	CACNA1A EIF3A NCAPH SCAF8 EIF4B	9.68e-05	355	27	5	int:EIF3A
Interaction	JMJD6 interactions	DIDO1 SCAF8 SCAF4 SNRNP35	1.52e-04	205	27	4	int:JMJD6
Interaction	CLK3 interactions	RBM15 CCDC9 EPB41L1 SNRNP35	1.99e-04	220	27	4	int:CLK3
Interaction	PARP1 interactions	FGF2 DIDO1 ZNF106 RNF169 NCAPH ENDOG PHF3 FBXL6	2.34e-04	1316	27	8	int:PARP1
Interaction	SSRP1 interactions	DIDO1 RBM15 EIF3A ZNF592 PHF3 SCAF4	2.42e-04	685	27	6	int:SSRP1
Interaction	TOP1 interactions	DIDO1 RBM15 EIF3A PHF3 FBXL6 SCAF4	2.64e-04	696	27	6	int:TOP1
Interaction	POT1 interactions	NCAPH CCDC9 EPB41L1 EIF4B	2.65e-04	237	27	4	int:POT1
Interaction	SMC5 interactions	GIGYF2 DIDO1 RBM15 RNF169 PHF3 EIF4B SCAF4	2.69e-04	1000	27	7	int:SMC5
GeneFamily	RNA binding motif containing	RBM15 SCAF8 EIF4B SCAF4 SNRNP35	2.20e-06	213	19	5	725
GeneFamily	PHD finger proteins	DIDO1 PHF3	3.97e-03	90	19	2	88
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	FGF2 DIDO1 EIF3A ZNF592 SCAF4	3.85e-06	197	28	5	5835_UP
Drug	Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FGF2 CEP68 DOCK6 CCDC9 EPB41L1	4.05e-06	199	28	5	7465_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	GIGYF2 DIDO1 SCAF8 PHF3	6.67e-05	180	28	4	4541_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	GIGYF2 DIDO1 NCAPH SCAF8	7.11e-05	183	28	4	7498_DN
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	FGF2 DIDO1 PHF3 SCAF4	7.73e-05	187	28	4	1242_UP
Drug	5666823; Down 200; 100uM; MCF7; HG-U133A	DIDO1 AMN DOCK6 EPB41L1	9.09e-05	195	28	4	609_DN
Drug	15d-PGJ2; Down 200; 10uM; SKMEL5; HG-U133A	CEP68 RBM15 ENDOG SCAF8	9.28e-05	196	28	4	564_DN
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	FGF2 DIDO1 NCAPH SCAF4	9.28e-05	196	28	4	7127_DN
Drug	Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A	DOCK6 NCAPH EPB41L1 SCAF4	9.28e-05	196	28	4	5504_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	FGF2 PHF3 CCDC9 FBXL6	9.46e-05	197	28	4	7360_UP
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FGF2 CEP68 EPB41L1 FBXL6	9.46e-05	197	28	4	6258_UP
Drug	Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CEP68 PHF3 CCDC9 SCAF4	9.46e-05	197	28	4	6099_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	FGF2 DIDO1 PHF3 EPB41L1	9.46e-05	197	28	4	2070_DN
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A	DIDO1 EPB41L1 FBXL6 SCAF4	9.46e-05	197	28	4	4963_DN
Drug	genistein; Down 200; 10uM; MCF7; HG-U133A	CACNA1A AMN ZFR2 FBXL6	9.65e-05	198	28	4	382_DN
Drug	nocodazole; Down 200; 1uM; MCF7; HG-U133A	CEP68 DIDO1 EIF3A CCDC9	9.65e-05	198	28	4	621_DN
Drug	Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A	FGF2 DOCK6 ZNF592 PHF3	9.84e-05	199	28	4	7365_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	CEP68 ZNF592 CCDC9 SCAF4	9.84e-05	199	28	4	6321_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A	CACNA1A ZNF592 PHF3 CCDC9	1.00e-04	200	28	4	2175_DN
Disease	syndrome (implicated_via_orthology)	SCAF8 SCAF4	1.32e-04	18	28	2	DOID:225 (implicated_via_orthology)
Disease	schizophrenia, anorexia nervosa	GIGYF2 ZNF592	9.53e-04	48	28	2	MONDO_0005090, MONDO_0005351
Disease	keratoconus	ZNF106 EIF3A	1.79e-03	66	28	2	MONDO_0015486
Disease	creatinine measurement	NUDT19 GIGYF2 ZNF592 SCAF8 EIF4B	2.22e-03	995	28	5	EFO_0004518
Disease	age at first birth measurement	CACNA1A AMN	5.79e-03	120	28	2	EFO_0009101

Protein segments in the cluster

Peptide	Gene	Start	Entry
ERPDHGRARARDQRW	CACNA1A	2231	O00555
SRDARWERREPALRG	CEP68	406	Q76N32
AGRLRWRRHEAAAPA	AMN	386	Q9BXJ7
RRARAAPRPRSAEDW	FBXL6	11	Q8N531
RRRDGWSLDRDRGDR	RBM15	616	Q96T37
SGDRRSPSRRWHDRG	MMTAG2	246	Q9BU76
IHRDRDWERERRLPS	EPB41L1	526	Q9H4G0
SWRDRVRQDPRHFLR	NUDT19	166	A8MXV4
EERRLQREHRDHQWP	HS6ST3	436	Q8IZP7
DSEGERRPAWTDRRR	DOCK6	416	Q96HP0
RLAGSRRDGERWRPH	GIGYF2	221	Q6Y7W6
RPPRRIADEDRGNWR	EIF3A	996	Q14152
RGNWRHADDDRPPRR	EIF3A	1006	Q14152
DRGPWRNADDDRIPR	EIF3A	1116	Q14152
EDRFRRPRDEGGWRR	EIF3A	1236	Q14152
DRREESRRHGRNWGG	CCDC9	211	Q9Y3X0
ERDWDRPREWDRHRD	DIDO1	2126	Q9BTC0
RPREWDRHRDKDSSR	DIDO1	2131	Q9BTC0
AAWEAALPRRRPRRH	FGF2	36	P09038
SNRDRREWGRRSPDR	SCAF4	1026	O95104
REWGRRSPDRDRHRD	SCAF4	1031	O95104
HRDFDDRRRPWERQR	SCAF8	1146	Q9UPN6
LERRPRERHPSWRSE	EIF4B	396	P23588
EGWRRRREDARAAPG	ENDOG	21	Q14249
HPAARARRRAWHGAR	PRR34	86	Q9NV39
PGWARRRARDDGQAD	RNF169	111	Q8NCN4
GPDHWRFRPRRKQDA	NCAPH	441	Q15003
LRRWHAERRRLEEEP	ZFR2	536	Q9UPR6
GRWGRPEAHRRVEAR	ZNF592	961	Q92610
RDHDRGREKRWQERE	SNRNP35	201	Q16560
RRPERRHSDPWGRQD	PHF3	1891	Q92576
QERRRWQQRDRHFPE	TCHH	1281	Q07283
SDDRRPQWRREDRIP	ZNF106	96	Q9H2Y7
GRAHRRHPQERWRLE	ZFTA	411	C9JLR9